Articles

SelectScience—Incubation monitoring for cancer cell line quality control and banking
“Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication.” Editorial

Microscopy Today—Towards Precision Medicine: The Ellison Institute and Olympus Partnership is Working to Change the Future of Cancer Medicine
“As explicitly translational paradigms like precision medicine have advanced, the Ellison Institute for Transformative Medicine of the University of Southern California and Olympus formed a partnership to address some of the key scientific, technological, and computational challenges associated with evolving needs in cancer medicine. This article highlights some of the specific microscopy innovation and scientific challenges addressed by the partnership.” Author: Brendan Brinkman

Application Notes

Automated Analysis of Label-Free Organoid Imaging Data
This study used cellSens™ software’s macro function to make batch image analysis workflows for label-free organoid data. The results where then compared to a CellTiter-Glo 3D cell viability assay to assess the analysis speed and determine the accuracy and sensitivity of object detection and measurement.

Talks

Seungil Kim, PhD, Ellison Institute Staff Scientist, spoke at a SLAS 2021 special interest group session on the topic of “High content imaging approaches to organs-on-chips: recent advancements and future prospects” (Jan 26, 2021)
Watch the presentation

Shannon Mumenthaler, PhD, Ellison Institute Lab Director, spoke at the Olympus Discovery Summit on the topic of “High-Content Imaging of 3D Cancer Models” (Apr 27, 2021):
Watch the presentation